Patents by Inventor Zohar ZAFRIR

Zohar ZAFRIR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250043278
    Abstract: The present invention is directed to a method for treating cancer in a subject determined as having the presence of a G600>A substitution, a C601>T substitution, or both, in the B cell lymphoma 2 (BCL2) gene of a cell.
    Type: Application
    Filed: October 28, 2024
    Publication date: February 6, 2025
    Inventors: Tamir TULLER, Ofek SCHNITZER, Hadas ZUR, Zohar ZAFRIR
  • Publication number: 20230107824
    Abstract: Modified genomes of an organism comprising at least one coding sequence comprising at least one mutation, wherein the mutation generates an underrepresented sequence that is underrepresented in the unmodified genome of the organism are provided. Organism and cells comprising the modified genomes of the invention, pharmaceutical compositions comprising the organisms and cells of the invention, as well as methods of making the modified genomes are also provided.
    Type: Application
    Filed: October 6, 2022
    Publication date: April 6, 2023
    Inventors: Tamir TULLER, Yoram ZARAI, Modi ROOPIN, Zohar ZAFRIR
  • Publication number: 20220042010
    Abstract: The present invention is directed to a method for treating cancer in a subject determined as having the presence of a G600>A substitution, a C601>T substitution, or both, in the B cell lymphoma 2 (BCL2) gene of a cell.
    Type: Application
    Filed: August 10, 2021
    Publication date: February 10, 2022
    Inventors: Tamir TULLER, Ofek SCHNITZER, Hadas ZUR, Zohar ZAFRIR